Diabetes is a significant challenge for the global healthcare system: The International Diabetes Federation (IDF) estimates that healthcare expenditures already amount to USD 966 billion. In the coming years, the number of diabetics is expected to continue to increase significantly, and by 2045 it is estimated that 783 million people worldwide be living with the disease.
Against this background, the number of people suffering from diabetic nephropathy, kidney disease caused by diabetes, which affects approximately 40% of diabetes mellitus patients during the course of their disease, is expected to increase massively in the coming years.
We are pleased to be able to make an important contribution to the treatment of diabetic nephropathy with our studies. In the following white paper „New Strategies to improve clinical outcome for diabetic kidney disease“ you will find a study overview of the current research results in this field.
